Search Results - "Lasser, L"

Estrogen plus Progestin and the Risk of Coronary Heart Disease by Manson, JoAnn E, Hsia, Judith, Johnson, Karen C, Rossouw, Jacques E, Assaf, Annlouise R, Lasser, Norman L, Trevisan, Maurizio, Black, Henry R, Heckbert, Susan R, Detrano, Robert, Strickland, Ora L, Wong, Nathan D, Crouse, John R, Stein, Evan, Cushman, Mary

“…This report provides the final results of the Women's Health Initiative trial comparing estrogen plus progestin and placebo in postmenopausal women. For the…”
Get full text

Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes by Van Hees, S., Bourgeois, S., Van Vlierberghe, H., Sersté, T., Francque, S., Michielsen, P., Sprengers, D., Reynaert, H., Henrion, J., Negrin Dastis, S., Delwaide, J., Lasser, L., Decaestecker, J., Orlent, H., Janssens, F., Robaeys, G., Colle, I., Stärkel, P., Moreno, C., Nevens, F., Vanwolleghem, T., Van Hees, Stijn, Bourgeois, Stefan, Van Vlierberghe, Hans, Sersté, Thomas, Francque, Sven, Michielsen, Peter, Sprengers, Dirk, Reynaert, Hendrik, Henrion, Jean, Negrin‐Dastis, Sergio, Delwaide, Jean, Lasser, Luc, Decaestecker, Jochen, Orlent, Hans, Janssens, Filip, Robaeys, Geert, Colle, Isabelle, Stärkel, Peter, Moreno, Christophe, Nevens, Frederik, Vanwolleghem, Thomas

“…Summary Background Stopping nucleos(t)ide analogues (NA) after hepatitis B e antigen (HBeAg) seroconversion is associated with high relapse rates in Asian…”
Get full text

A phase II study of human allogeneic liver-derived progenitor cell therapy for acute-on-chronic liver failure and acute decompensation by Nevens, Frederik, Gustot, Thierry, Laterre, Pierre-François, Lasser, Luc L., Haralampiev, Lyudmil E., Vargas, Victor, Lyubomirova, Desislava, Albillos, Agustin, Najimi, Mustapha, Michel, Sébastien, Stoykov, Ivaylo, Gordillo, Noelia, Vainilovich, Yelena, Barthel, Virginie, Clerget-Chossat, Nathalie, Sokal, Etienne M.

“…Human allogeneic liver-derived progenitor cells (HALPC, HepaStem®; Promethera Biosciences, Mont-Saint-Guibert, Belgium) are an advanced therapy medicinal…”
Get full text

Calcium plus Vitamin D Supplementation and the Risk of Fractures by Jackson, Rebecca D, LaCroix, Andrea Z, Gass, Margery, Wallace, Robert B, Robbins, John, Lewis, Cora E, Bassford, Tamsen, Beresford, Shirley A.A, Black, Henry R, Blanchette, Patricia, Bonds, Denise E, Brunner, Robert L, Brzyski, Robert G, Caan, Bette, Cauley, Jane A, Chlebowski, Rowan T, Cummings, Steven R, Granek, Iris, Hays, Jennifer, Heiss, Gerardo, Hendrix, Susan L, Howard, Barbara V, Hsia, Judith, Hubbell, F. Allan, Johnson, Karen C, Judd, Howard, Kotchen, Jane Morley, Kuller, Lewis H, Langer, Robert D, Lasser, Norman L, Limacher, Marian C, Ludlam, Shari, Manson, JoAnn E, Margolis, Karen L, McGowan, Joan, Ockene, Judith K, O'Sullivan, Mary Jo, Phillips, Lawrence, Prentice, Ross L, Sarto, Gloria E, Stefanick, Marcia L, Van Horn, Linda, Wactawski-Wende, Jean, Whitlock, Evelyn, Anderson, Garnet L, Assaf, Annlouise R, Barad, David

“…The efficacy of calcium with vitamin D supplementation in preventing hip and other fractures in healthy postmenopausal women remains equivocal. In this Women's…”
Get full text

Low-Fat Dietary Pattern and Risk of Cardiovascular Disease: The Women's Health Initiative Randomized Controlled Dietary Modification Trial by Howard, Barbara V, Van Horn, Linda, Hsia, Judith, Manson, JoAnn E, Stefanick, Marcia L, Wassertheil-Smoller, Sylvia, Kuller, Lewis H, LaCroix, Andrea Z, Langer, Robert D, Lasser, Norman L, Lewis, Cora E, Limacher, Marian C, Margolis, Karen L, Mysiw, W. Jerry, Ockene, Judith K, Parker, Linda M, Perri, Michael G, Phillips, Lawrence, Prentice, Ross L, Robbins, John, Rossouw, Jacques E, Sarto, Gloria E, Schatz, Irwin J, Snetselaar, Linda G, Stevens, Victor J, Tinker, Lesley F, Trevisan, Maurizio, Vitolins, Mara Z, Anderson, Garnet L, Assaf, Annlouise R, Bassford, Tamsen, Beresford, Shirley A. A, Black, Henry R, Brunner, Robert L, Brzyski, Robert G, Caan, Bette, Chlebowski, Rowan T, Gass, Margery, Granek, Iris, Greenland, Philip, Hays, Jennifer, Heber, David, Heiss, Gerardo, Hendrix, Susan L, Hubbell, F. Allan, Johnson, Karen C, Kotchen, Jane Morley

“…CONTEXT Multiple epidemiologic studies and some trials have linked diet with cardiovascular disease (CVD) prevention, but long-term intervention data are…”
Get full text

Calcium plus Vitamin D Supplementation and the Risk of Colorectal Cancer by Wactawski-Wende, Jean, Kotchen, Jane Morley, Anderson, Garnet L, Assaf, Annlouise R, Brunner, Robert L, O'Sullivan, Mary Jo, Margolis, Karen L, Ockene, Judith K, Phillips, Lawrence, Pottern, Linda, Prentice, Ross L, Robbins, John, Rohan, Thomas E, Sarto, Gloria E, Sharma, Santosh, Stefanick, Marcia L, Van Horn, Linda, Wallace, Robert B, Whitlock, Evelyn, Bassford, Tamsen, Beresford, Shirley A.A, Black, Henry R, Bonds, Denise E, Brzyski, Robert G, Caan, Bette, Chlebowski, Rowan T, Cochrane, Barbara, Garland, Cedric, Gass, Margery, Hays, Jennifer, Heiss, Gerardo, Hendrix, Susan L, Howard, Barbara V, Hsia, Judith, Hubbell, F. Allan, Jackson, Rebecca D, Johnson, Karen C, Judd, Howard, Kooperberg, Charles L, Kuller, Lewis H, LaCroix, Andrea Z, Lane, Dorothy S, Langer, Robert D, Lasser, Norman L, Lewis, Cora E, Limacher, Marian C, Manson, JoAnn E

“…Supplemental calcium and vitamin D have been associated with a reduced risk of colorectal cancer in epidemiologic and polyp-prevention studies, but evidence…”
Get full text

Low-Fat Dietary Pattern and Risk of Invasive Breast Cancer: The Women's Health Initiative Randomized Controlled Dietary Modification Trial by Prentice, Ross L, Caan, Bette, Chlebowski, Rowan T, Patterson, Ruth, Kuller, Lewis H, Ockene, Judith K, Margolis, Karen L, Limacher, Marian C, Manson, JoAnn E, Parker, Linda M, Paskett, Electra, Phillips, Lawrence, Robbins, John, Rossouw, Jacques E, Sarto, Gloria E, Shikany, James M, Stefanick, Marcia L, Thomson, Cynthia A, Van Horn, Linda, Vitolins, Mara Z, Wactawski-Wende, Jean, Wallace, Robert B, Wassertheil-Smoller, Sylvia, Whitlock, Evelyn, Yano, Katsuhiko, Adams-Campbell, Lucile, Anderson, Garnet L, Assaf, Annlouise R, Beresford, Shirley A. A, Black, Henry R, Brunner, Robert L, Brzyski, Robert G, Ford, Leslie, Gass, Margery, Hays, Jennifer, Heber, David, Heiss, Gerardo, Hendrix, Susan L, Hsia, Judith, Hubbell, F. Allan, Jackson, Rebecca D, Johnson, Karen C, Kotchen, Jane Morley, LaCroix, Andrea Z, Lane, Dorothy S, Langer, Robert D, Lasser, Norman L, Henderson, Maureen M

“…CONTEXT The hypothesis that a low-fat dietary pattern can reduce breast cancer risk has existed for decades but has never been tested in a controlled…”
Get full text

Comorbidities and concomitant medications in patients with chronic hepatitis C virus infection receiving second-generation direct-acting antiviral regimens in Belgium: an observational study by Bourgeois, S, Mulkay, J P, Cool, M, Verhelst, X, Robaeys, G, Lasser, L, Lefebvre, V, Colle, I, Van Steenkiste, C, Decaestecker, J, Coulon, S, Venken, K, Vanwolleghem, T

“…To describe comorbidities and concomitant medications in patients initiating treatment for hepatitis C virus (HCV) infection with direct-acting antiviral (DAA)…”
Get more information

Hepatitis C virus (HCV) prevalence estimation in the adult general population in Belgium : a meta-analysis by Muyldermans, G, Bielen, R, Botterman, R, Bourgeois, S, Colle, I, Deressa, B, Devolder, G, Horsmans, Y, Hutse, V, Lanthier, N, Lasser, L, Platteau, S, Robaeys, G, Suin, V, Verhelst, X, Van Vlierberghe, H, Van Baelen, L

“…Although multiple HCV prevalence studies were recently performed in the general population from Belgium, they suffer from a lack of geographical…”
Get more information

Usefulness of Baseline Lipids and C-Reactive Protein in Women Receiving Menopausal Hormone Therapy as Predictors of Treatment-Related Coronary Events by Bray, Paul F., MD, Larson, Joseph C., MS, LaCroix, Andrea Z., MPH, PhD, Manson, JoAnn, MD, DrPH, Limacher, Marian C., MD, Rossouw, Jacques E., MD, Lasser, Norman L., MD, PhD, Lawson, William E., MD, Stefanick, Marcia L., PhD, Langer, Robert D., MD, MPH, Margolis, Karen L., MD

“…Blood lipids and high-sensitivity C-reactive protein (hs-CRP) are altered by hormone therapy. The goal of the present study was to determine whether lipids and…”
Get full text

Low-Fat Dietary Pattern and Risk of Colorectal Cancer: The Women's Health Initiative Randomized Controlled Dietary Modification Trial by Beresford, Shirley A. A, Johnson, Karen C, Ritenbaugh, Cheryl, Lasser, Norman L, Snetselaar, Linda G, Black, Henry R, Anderson, Garnet L, Assaf, Annlouise R, Bassford, Tamsen, Bowen, Deborah, Brunner, Robert L, Brzyski, Robert G, Caan, Bette, Chlebowski, Rowan T, Gass, Margery, Harrigan, Rosanne C, Hays, Jennifer, Heber, David, Heiss, Gerardo, Hendrix, Susan L, Howard, Barbara V, Hsia, Judith, Hubbell, F. Allan, Jackson, Rebecca D, Kotchen, Jane Morley, Kuller, Lewis H, LaCroix, Andrea Z, Lane, Dorothy S, Langer, Robert D, Lewis, Cora E, Manson, JoAnn E, Margolis, Karen L, Mossavar-Rahmani, Yasmin, Ockene, Judith K, Parker, Linda M, Perri, Michael G, Phillips, Lawrence, Prentice, Ross L, Robbins, John, Rossouw, Jacques E, Sarto, Gloria E, Stefanick, Marcia L, Van Horn, Linda, Vitolins, Mara Z, Wactawski-Wende, Jean, Wallace, Robert B, Whitlock, Evelyn

“…CONTEXT Observational studies and polyp recurrence trials are not conclusive regarding the effects of a low-fat dietary pattern on risk of colorectal cancer,…”
Get full text

A multicentre, observational study on demographic and disease characteristics of patients seeking care for chronic hepatitis C in Belgium in 2016 by Bourgeois, S, Mulkay, J P, Lasser, L, Robaeys, G, Bastens, B, Delwaide, J, Pollet, S, Van den Enden, M

“…Direct-acting antivirals provide interferon-free treatments for chronic hepatitis C (CHC) virus infection. In Belgium, in 2016, access to these agents was…”
Get more information

Long-Term Safety and Efficacy of a Cholesterol-Lowering Diet in Children With Elevated Low-Density Lipoprotein Cholesterol: Seven-Year Results of the Dietary Intervention Study in Children (DISC) by Obarzanek, Eva, Kimm, Sue Y. S, Barton, Bruce A, Van Horn, Linda, Kwiterovich Jr, Peter O, Simons-Morton, Denise G, Hunsberger, Sally A, Lasser, Norman L, Robson, Alan M, Franklin Jr, Frank A, Lauer, Ronald M, Stevens, Victor J, Friedman, Lisa Aronson, Dorgan, Joanne F, Greenlick, Merwyn R, on Behalf of DISC Collaborative Research Group

“…Diets reduced in fat and cholesterol are recommended for children over 2 years of age, yet long-term safety and efficacy are unknown. This study tests the…”
Get full text

Estrogen plus Progestin and Risk of Benign Proliferative Breast Disease by ROHAN, Thomas E, NEGASSA, Abdissa, CHLEBOWSKI, Rowan T, LASSER, Norman L, MCTIERNAN, Anne, SCHENKEN, Robert S, GINSBERG, Mindy, WASSERTHEIL-SMOLLER, Sylvia, PAGE, David L

“…Women with benign proliferative breast disease are at increased risk of subsequent breast cancer. Estrogens and progesterone exert proliferative effects on…”
Get full text

A lady with NASH and choreoathetosis by Ghys, C., Kong, M.-F., Glibert, G., Lasser, L., Karmali, R.

“…We describe a case of acquired hepatocerebral degeneration (AHD) presenting with confusion and worsening memory problems since her discharge from the…”
Get full text

Long-term (7-year-) treatment with lamivudine monotherapy in HBV-associated glomerulonephritis by Mesquita, M, Lasser, L, Langlet, P

“…Glomerulonephritis (GN) is an uncommon but well-described complication of chronic hepatitis B virus (HBV) infection. HBV-related membranous nephropathy (MN)…”
Get more information

P1111 ANRS HC15 NRFI: LONG-TERM MAINTENANCE THERAPY WITH A COMBINATION OF RIBAVIRIN AND PEGYLATED INTERFERON IN CHRONIC HEPATITIS C. RESULTS OF A MULTICENTER RANDOMIZED CONTROLLED TRIAL by Guyader, D, Bellissant, E, Asselah, T, Bronowicki, J.P, Abergel, A, Lasser, L, Tran, A, Bourlière, M, Samuel, D, Wartelle, C, Beaugrand, M, Trépo, C, Riachi, G, Attali, P, D'alteroche, L, Gournay, J, Vinel, J.P, Schnee, M, Henrion, J, Doffoel, M, Hillon, P, Adler, M, Turlin, B, Renault, A, Bedossa, P, Calès, P, Delwaide, J

Get full text

Clinical trial: a randomized trial of pegylated-interferon-alpha-2a plus ribavirin with or without amantadine in treatment-naïve or relapsing chronic hepatitis C patients by Langlet, P, D'Heygere, F, Henrion, J, Adler, M, Delwaide, J, Van Vlierberghe, H, Mulkay, J P, Lasser, L, Brenard, R, Horsmans, Y, Michielsen, P, Laureys, A, Nevens, F

“…The combination therapy of pegylated-interferon-alpha2a plus ribavirin is considered as the standard of care for patients with chronic hepatitis C. A sustained…”
Get full text

Clinical trial: a randomized trial of pegylated‐interferon‐α‐2a plus ribavirin with or without amantadine in treatment‐naïve or relapsing chronic hepatitis C patients by LANGLET, P., D’HEYGERE, F., HENRION, J., ADLER, M., DELWAIDE, J., VAN VLIERBERGHE, H., MULKAY, J. P., LASSER, L., BRENARD, R., HORSMANS, Y., MICHIELSEN, P., LAUREYS, A., NEVENS, F.

“…Summary Background  The combination therapy of pegylated‐interferon‐α2a plus ribavirin is considered as the standard of care for patients with chronic…”
Get full text

Characteristics, treatment, and virologic responses of chronic hepatitis C patients treated with peginterferon alfa-2a and ribavirin in belgium: a sub-analysis of the PROPHESYS study by Mulkay, J P, Bourgeois, S, Lasser, L, De Galocsy, C, Tomasovic, S, Horsmans, Y, Van Vlierberghe, H

“…PROPHESYS was a prospective, international cohort study of monoinfected, treatment-naive chronic hepatitis C patients treated with a combination of…”
Get more information